THE HOSPITAL FOR SICK CHILDREN (SICKKIDS)
TORONTO, CANADA
The Hospital for Sick Children (SickKids), affiliated with the University of Toronto, is Canada's most research-intensive hospital and the largest centre dedicated to improving children's health in the country. In 2022 Newsweek named SickKids as the No.1 Paediatric Hospital in the world. As innovators in child health, SickKids improve the health of children by integrating care, research, and teaching. SickKids provides the best in complex and specialised care by creating scientific and clinical advancements, sharing knowledge and expertise, and championing the development of an accessible, comprehensive and sustainable child health system. SickKids are working with Micregen on various pre-clinical studies.
GREAT ORMOND STREET HOSPITAL
LONDON
Together, Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH) have been at the forefront of many breakthroughs in paediatric medicine. In 2022, Newsweek named GOSH as the No.3 paediatric hospital in the world.Micregen has worked with specialists at GOSH for over ten years, contributing to multiple pre-clinical studies and receiving clinical advice in preparation for trials. In partnership with UCL, Micregen was awarded an MRC grant and is also financing a dedicated PhD student to further advance research into Secretomix® as a therapeutic option for NEC.
This programme is led by Dr. Stavros Loukogeorgakis and Dr. Jay Sivaraj, both recognised experts in neonatal research and regenerative medicine.
THE UNIVERSITY OF BRADFORD
BRADFORD
The University of Bradford is collaborating with Micregen on studying the validation of Secretomix® as a therapeutic for Neurodegeneration. The studies have been designed to determine the efficacy of Secretomix® in various disease models.